Liminal BioSciences Inc. PFSCF

Primary Symbol: LMNL

Healthcare Biotechnology

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.

NDAQ:LMNL - Post by User

Liminal BioSciences Inc. > FINANCING REQUIREMENT

<< Previous

Bullboard Posts

Next >>

Comment by aldo451on Aug 18, 2021 12:14am

74 Views

Post# 33721981

RE:FINANCING REQUIREMENT

Working hard buddy. Citing standard disclaimer information...lol. Anything to put a negative spin on the PR...what a clown

4Justice wrote: From the MD&A page 6

Financial and Other Corporate Impacts

Given that our activities continue to be in the R&D stage, management has concluded we will need additional sources of financing to ensure we have sufficient funds to continue our operations for at least the next 12 months.